Delivery Order SPE2DB24D2205-SPE2DB25FEGSL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.79 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28-count packages. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a discrete transaction within the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,544.36 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 8, 2025, with a completion date of August 11, 2025. This firm fixed-price delivery order is a competitive award with no set-aside designation and represents a child contract under AmerisourceBergen's broader relationship with federal medical procurement. The product will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $4,498.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units on August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a $3,438.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was made to AmerisourceBergen's Corporate Office division, with performance executed at the company's headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, by the Defense Logistics Agency for the supply of Lo Loestrin Fe 1-10 tablets (28-count packaging). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,018.50 with an ultimate completion date of August 19, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $38,236.07 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lo Loestrin Fe 1/10 tablets in quantities of 28 units. This non-competitive, firm fixed-price delivery order is set to be completed by August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical delivery executed under the company's existing contract vehicle...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGSLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,733.20 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract covers the supply of this specific pharmaceutical product to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 8/22/25 |